Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Eagle Pharmaceutical (NASDAQ: EGRX)

$79.88 USD -$1.95 (-2.38%)
Last Price $79.88
Net Change $-1.95 (-2.38%)
Bid $0
Ask Price $0
Open Price $82.04
Previous Close Price $81.83
High Price $82.88
Low Price $78.75
Number of Trades 1,883
Volume 299,500
Fifty Two Week High $87.78 (2016-11-10)
Fifty Two Week Low $33.02 (2016-04-12)
Average Daily Volume 321,563
Share Outstanding 15,230 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $3.52 (2017-03-01)
2nd Quarter Earnings $0.73 (2016-11-09)
3nd Quarter Earnings $0.8 (2016-08-09)
4th Quarter Earnings $-0.06 (2016-05-09)
PE Ratio $16.4
EPS Growth $-20.36
Recent Earnings $3.52
Annual EPS $4.99
Last Quarter EPS $
Market Capitalization $1.22B
Insider Shareholders % 0.188%
Annual Revenue $0B
No. Shares Outstanding 15,230
Inst. Shareholder % 0%
Annual Net Income $0.08B
TTM Net Profit Margin $42.99
1-Year Return 111.04%
3-Year Return 523.58%
5-Year Return 522.6%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -20.360001%
Dividends per Share $
Stock Split Ratio
Beta 1.53
Eagle Pharmaceuticals Inc. is a specialty pharmaceutical company. It focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The Company markets EP-1101 to treat heparin-induced thrombocytopenia. It develops EP-3101 EP-3102 Ryanodex and EP-4104. Eagle Pharmaceuticals Inc. is based in Woodcliff Lake New Jersey.

No News found for EGRX